Brief: Moberg Pharma Signs Exclusive Agreement For Emtrix In Middle East And Africa
Nov 5 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* MOBERG PHARMA SIGNS EXCLUSIVE AGREEMENT FOR EMTRIX® IN THE
MIDDLE EAST AND AFRICA
* MOBERG PHARMA - SIGNED AN EXCLUSIVE AGREEMENT WITH
MUNDIPHARMA
TO COMMERCIALIZE EMTRIX® IN MIDDLE EAST AND AFRICA, STARTING IN
2019
Source text for Eikon: ID:nWkrcbKl9H
Further company coverage: MBPH.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains